News on Medial

Morphing Machines raises Rs 38.36 Cr in Series A round led by IAN Alpha Fund

EntrackrEntrackr · 3h ago
Morphing Machines raises Rs 38.36 Cr in Series A round led by IAN Alpha Fund
Medial

Morphing Machines, a Bengaluru-based fabless semiconductor IP company, has raised Rs 38.36 crore ($4.32 million) in a Series A funding round led by IAN Alpha Fund, with participation from Speciale Invest, IvyCap Ventures, and Navam Capital. Existing investors from the company’s seed round, including Speciale Invest, IvyCap Ventures, Navam Capital, Golden Sparrow Ventures, IIMA Ventures, and DeVC, also participated in this round. The proceeds will be used to build and test the company’s first chip, expand its engineering team from 50 to over 90 members, and launch pilot projects with data center customers. Morphing Machines will also begin commercial deployments in India, the US, and Europe. Founded by Deepak Shapeti, Dr. Ranjani Narayan, and Prof. S.K. Nandy, Morphing Machines develops next-generation semiconductor architectures, building REDEFINE, a manycore processor capable of handling AI, data analytics, and high-performance computing, focusing on speed and energy efficiency. Over the next 12 to 24 months, the company plans to complete its first proof-of-silicon, enhance its software toolchain, and expand its customer base across data centers, AI applications, and enterprise infrastructure.

Related News

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 3m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

EndureAir raises $2.85 Mn led by IAN Alpha Fund

EntrackrEntrackr · 26d ago
EndureAir raises $2.85 Mn led by IAN Alpha Fund
Medial

EndureAir raises $2.85 Mn led by IAN Alpha Fund EndureAir Systems, a deep-tech UAV (Unmanned Aerial Vehicle) and aerial robotics firm, has raised Rs 25 crore (about $2.85 million) in funding led by IAN Alpha Fund, with participation from IAN Angel Fund. The proceeds will be used to strengthen its UAV capabilities for the defense ecosystem, expand into enterprise markets, and accelerate the development of next-generation high-altitude logistics and aerial robotics platforms. Founded in 2018 by Dr. Abhishek along with his former students Rama Krishna and Chirag Jain, EndureAir designs and manufactures rugged, indigenous UAVs for logistics, defense, surveillance, and disaster response. Unlike drone assemblers, the brand develops both hardware and software fully in-house, leveraging over 15 years of rotorcraft research and backed by 8 patents in flight dynamics and autonomy. EndureAir’s UAV portfolio includes: Sabal, a heavy-lift logistics drone family (10–70 kg payloads) already inducted by the Indian Army’s Eastern Command; Vibhram, a long-endurance UAV that powered Telangana’s Medicine from the Sky vaccine delivery program; and Alakh, a nano-UAV series deployed in critical rescue missions from Chamoli cloudburst to the Turkey earthquake. It is also co-developing high-altitude logistics drones with Bharat Electronics Limited (BEL) and piloting missions in Bhutan with Druk Holding & Investments (DHI). The Noida-based startup competes with players like IdeaForge, Garuda Aerospace, and NewSpace Research.

Download the medial app to read full posts, comements and news.